Kathleen L. Mattis

Ms. Mattis has served as Chief Financial Officer of Neuronascent from November 2006 to 2010 and Secretary to the Board of Directors since May 2004. From 2004 to 2006, she was the principal business advisor for Neuronascent’s fiscal operations. Prior to joining Neuronascent, since 2003, she served as the Chief Financial Officer of J. Craig Venter Institute. Previously, she was Vice President of Finance for Neuralstem, Inc.; Controller at Celera Genomics; Founder, Vice President of Finance and Controller for ARIAD Pharmaceuticals, Inc. and Director of Finance for Centocor, Inc. She also served as Controller of Novo Nordisk Pharmaceuticals, Inc. after holding multiple financial management positions at Squibb Corporation in Princeton, NJ and Kraft, Inc. in Chicago, IL. Ms. Mattis has a BS from Drexel University and MBA from the Wharton School of University of Pennsylvania.